Pathophysiology of weakness in a patient with congenital end-plate acetylcholinesterase deficiency (Q34122100)

31 July 2017

Pathophysiology of weakness in a patient with congenital end-plate acetylcholinesterase deficiency (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

Nobuo Kohara

1

1 reference

31 July 2017

Thy-Sheng Lin

2

1 reference

31 July 2017

Takayasu Fukudome

3

1 reference

31 July 2017

Jun Kimura

4

1 reference

31 July 2017

Takashi Sakamoto

5

1 reference

31 July 2017

Ryuji Kaji

6

1 reference

31 July 2017

Hiroshi Shibasaki

7

1 reference

31 July 2017

language of work or name

1 reference

1 April 2002

1 reference

31 July 2017

1 reference

31 July 2017

25

1 reference

31 July 2017

4

1 reference

31 July 2017

585-592

1 reference

Pancuronium improves the neuromuscular transmission defect of human organophosphate intoxication.

31 July 2017

1 reference

Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic)

21 January 2018

1 reference

Congenital endplate acetylcholinesterase deficiency

21 January 2018

1 reference

Characterization of the relationship between motor end-plate jitter and the safety factor.

21 January 2018

1 reference

Edrophonium: an aid in the diagnosis of acute organophosphate poisoning.

21 January 2018

1 reference

Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme

21 January 2018

1 reference

Repetitive CMAPs: mechanisms of neural and synaptic genesis

21 January 2018

1 reference

Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.10073

1 reference

31 July 2017

1 reference